pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Product pms-IRBESARTAN 150 mg Tablet Issue Health products - Contamination What to do Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.

The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Verify whether your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

RA-82479